What is a Tumor Agnostic Therapy?
In May 2017, the U.S. Food and Drug Administration (FDA) approved the first tumor/tissue agnostic therapy. These drugs are approved for use for any tumor that has...
Read MoreTrue or False?
2% of breast cancer patients are diagnosed initially with stage IV metastatic disease. Answer: False Between 6-10% of breast cancer patients are diagnosed...
Read MoreExpanding Eligibility Criteria
Every clinical trial has a list of eligibility criteria. This list details who can take part in a particular study. These criteria are necessary because ruling...
Read MoreDragon Boat Racing
Up until the late 1990s, women who had been diagnosed with breast cancer were told not to take part in upper body exercise. The concern: it would increase their...
Read MoreGenetic vs. Genomic Testing
The terms genetic testing and genomic testing are often used in articles about cancer research. They sound similar, but they are not the same. Below are a...
Read MoreAbout MBC Awareness Day
In 2009, October 13 was established as Metastatic Breast Cancer Awareness Day. Breast Cancer Awareness Month had been on the national calendar since 1985. But its...
Read MoreTreating Brain Metastases
Studies suggest that between 15 and 30 percent of women and men with metastatic breast cancer will develop brain metastases. This number has been increasing as...
Read MoreOS vs. PFS: What You Need to Know
Clinical trials are set up to look at specific outcomes. In some trials, researchers look at progression-free survival (PFS), a measure of how long someone is on...
Read MoreHow to Ask Your Doctor About Clinical Trials
As a woman or man living with metastatic breast cancer, you may have thought about whether a clinical trial would be a good option for your care. But if your...
Read MoreSEARCH OUR SITE
for past articles or specific information.